Discipline of Physiotherapy, University of Dublin, Trinity College, Dublin, Ireland.
Department of Hepatology, St James's Hospital, Dublin, Ireland.
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa195.
Physical activity (PA) is an important non-pharmacological treatment for non-alcoholic fatty liver disease (NAFLD). This study investigated the determinants of PA engagement and awareness of the World Health Organization (WHO) PA guidelines in patients with NAFLD.
Study participants were 101 patients with NAFLD (median age: 54 [IQR = 15] y; 53 men and 48 women) who completed 4 questionnaires: (1) a PA guideline awareness questionnaire; (2) a PA questionnaire assessing PA levels; and (3) 2 questionnaires assessing perceived barriers and motivators for engaging in PA. Binary logistic regression was performed to assess predictors of PA levels.
Twenty-four percent of participants correctly identified the recommended WHO weekly PA guidelines, and 39% adhered to the guidelines. Lack of willpower, time, and energy were the most frequently cited barrier domains. Scores for lack of willpower (odds ratio [OR] = 1.445, 95% CI = 1.088-1.919) and lack of resources (OR = 1.378, 95% CI = 1.003-1.893), and reporting 3 or more "significant" barrier domains (OR = 5.348, 95% CI = 1.792-15.873) were significant predictors of PA levels. Maintaining health and fitness was the most cited motivator domain and was a significant predictor (OR = 2.551, 95% CI = 1.253-5.208) of PA levels.
This study highlights the lack of awareness of the WHO PA guidelines and the key determinants of PA participation in patients with NAFLD. Determinants of PA should be identified at the individual level to create a personalized approach for PA maintenance for people with NAFLD to promote lifelong participation in PA.
This study closes a gap in the published data on the determinants of PA engagement in patients with NAFLD.
Physical inactivity is the fourth leading cause of global mortality and contributes to many chronic inflammatory diseases, including obesity, type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD). People with NAFLD engage in less physical activity compared with people who are healthy, and this study provides new information that clinicians can use to help these patients increase their physical activity participation.
体力活动(PA)是非酒精性脂肪性肝病(NAFLD)的重要非药物治疗方法。本研究旨在调查影响 NAFLD 患者参与体力活动和了解世界卫生组织(WHO)PA 指南的决定因素。
研究对象为 101 例 NAFLD 患者(中位年龄:54 [IQR=15]岁;53 名男性和 48 名女性),他们完成了 4 份问卷:(1)PA 指南知晓问卷;(2)评估 PA 水平的 PA 问卷;(3)评估参与 PA 的感知障碍和动机的 2 份问卷。采用二项逻辑回归分析评估 PA 水平的预测因素。
24%的参与者正确识别了推荐的 WHO 每周 PA 指南,39%的参与者遵循了该指南。缺乏意志力、时间和精力是最常被提及的障碍领域。缺乏意志力(比值比[OR] = 1.445,95%可信区间[CI] = 1.088-1.919)和缺乏资源(OR = 1.378,95%CI = 1.003-1.893)评分以及报告 3 个或更多“显著”障碍领域(OR = 5.348,95%CI = 1.792-15.873)是 PA 水平的显著预测因素。保持健康和健身是最常被提及的激励因素领域,也是 PA 水平的显著预测因素(OR = 2.551,95%CI = 1.253-5.208)。
本研究强调了患者对 WHO PA 指南缺乏认识以及影响 PA 参与的主要决定因素。应在个体层面确定 PA 的决定因素,为 NAFLD 患者制定个性化的 PA 维持方法,以促进其终身参与 PA。
本研究填补了 NAFLD 患者 PA 参与决定因素的发表数据空白。
体力活动不足是全球第四大死亡原因,也是许多慢性炎症性疾病的病因,包括肥胖、2 型糖尿病、心血管疾病和非酒精性脂肪性肝病(NAFLD)。与健康人群相比,NAFLD 患者的体力活动较少,本研究提供了新的信息,临床医生可以利用这些信息帮助这些患者增加体力活动参与度。